Dikser®K

Diclofenac and Serratiopeptidase tablet

Composition

Dikser® K

Each tablet contains
Diclofenac  Potassium   BP   50 mg.
Serratiopeptidase  IP           10 mg.

Indications

Dikser® K is indicated  as short-term treatment in the following acute conditions:

Painful musculoskeletal conditions.
Inflammation and oedama associated with trauma.
Acute attacks of gout.
Painful post-operative and post-traumatic inflammation and swelling.
Pain following dental surgery.
Flare-up of osteoarthrosis.
Non-articular rheumatism.
Soft tissue disorders such as sprains and strains.
Symptomatic treatment of primary dysmenorrhoea.

PRESENTATION & PACKAGING

Dikser® K       Yellow, round, biconvex, enteric-coated tablet.
                      Aluminium Strip Pack of 10 s.

For Precautions and Drug Interactions please consult full Product Information or write to us.

® - Registered Trade Mark of Quality Innovations and Pharmaceuticals (India) Pvt Ltd.

Disclaimer

 The drug information is intended for the use of a registered medical practitioner only. If you are not a medical professional, you should note that this document does not provide professional medical advice and is not intended to replace personal consultation with a qualified physician and should not be relied upon solely for final treatment decisions. Company reserves right to change Product presentation, display, capsule colors, tablet size,forms etc without prior notice.